[Pertussis vaccine in adolescents and adults].
Despite high immunisation rates in infancy, Bordetella pertussis is still circulating in industrialised countries, causing severe infections in infants too young to be vaccinated, as well as an important number of long lasting cough episodes in older children, adolescents and young adults. The limited duration of the protection resulting from vaccination in the 2 first years of life is probably responsible for the insufficient control of the disease. The development of acellular pertussis vaccines has allowed immunisation of school age children, and an adult formulation is now available. The indications of this vaccine will be discussed.
Lévy
J
J
Services de Pédiatrie, CHU Saint-Pierre, Bruxelles.
Swennen
B
B
Van Laethem
Y
Y
D000293:Adolescent; D000328:Adult; D006801:Humans; D010567:Pertussis Vaccine; D014917:Whooping Cough / Q000453:epidemiology / Q000517:prevention & control*
D010567:Pertussis Vaccine